Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels
Citations Over TimeTop 10% of 2012 papers
Abstract
Tumour recurrence frequently occurs after radiotherapy, but the characteristics, intratumoural localization and post-irradiation behaviour of radioresistant cancer cells remain largely unknown. Here we develop a sophisticated strategy to track the post-irradiation fate of the cells, which exist in perinecrotic regions at the time of radiation. Although the perinecrotic tumour cells are originally hypoxia-inducible factor 1 (HIF-1)-negative, they acquire HIF-1 activity after surviving radiation, which triggers their translocation towards tumour blood vessels. HIF-1 inhibitors suppress the translocation and decrease the incidence of post-irradiation tumour recurrence. For the first time, our data unveil the HIF-1-dependent cellular dynamics during post-irradiation tumour recurrence and provide a rational basis for targeting HIF-1 after radiation therapy.
Related Papers
- → Cancer stem cells and signaling pathways in radioresistance(2015)110 cited
- → The miR-199a-3p regulates the radioresistance of esophageal cancer cells via targeting the AK4 gene(2018)41 cited
- → Clinically relevant radioresistant cell line: a simple model to understand cancer radioresistance(2017)46 cited
- → Targeting the AKT/cyclin D1 pathway to overcome intrinsic and acquired radioresistance of tumors for effective radiotherapy(2016)31 cited